Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026

What the insiders did Net selling

By person

8 insiders · 9 transactions
0.2×

Johan (Thijs) Spoor holds only 0.2 times base salary in stock. $201.52K of shares against $680.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Johan (Thijs) Spoor last reported holding, valued at $3.15, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Lantheus Alpha Therapy, LLC entity
10% owner
—
$1.27M (5)
−$1.27M
11,273,364
9.88%
$35.48M
−3.5%
Lantheus Holdings, Inc. entity
10% owner
—
$357.18K (2)
−$357.18K
11,563,425
10.13%
$36.39M
−1.0%
Jonathan Robert Hunt
Chief Accounting Officer
$22.29K (1)
—
+$22.29K
59,800
0.0524%
$188.20K
+66.2%
Robert F Williamson III
Director
$19.95K (1)
—
+$19.95K
118,846
0.1041%
$374.03K
+178.0%
Lori A Woods
Director
—
—
—
183,460
0.1607%
$577.39K
+14.7%
Johan M. Spoor
Chief Executive Officer
—
—
—
64,033
0.0561%
$201.52K
+2,141%
Juan Graham
Chief Financial Officer
—
—
—
35,354
0.0310%
$111.27K
+1,649%
Heidi Henson
Director
—
—
—
25,975
0.0228%
$81.75K
—